Biotricity, Inc. (BTCY) Financials

BTCY Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2025 5.7 million 38.2 million
Sept. 30, 2025 6.3 million 38.0 million
June 30, 2025 6.0 million 36.8 million
March 31, 2025 5.6 million 35.7 million

BTCY Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -740291 6001
Sept. 30, 2025 415630 6001
June 30, 2025 -373389 5935
March 31, 2025 -400785 1.3 million

BTCY Net Income

No data available :(

BTCY Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 256357 - -
Sept. 30, 2025 308460 204614 674013
June 30, 2025 391292 13.5 million 803380
March 31, 2025 365145 13.5 million 929116

BTCY Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 ?
Sept. 30, 2025 ?
June 30, 2025 ?
March 31, 2025 ?

BTCY Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 - 623567 2.2 million -
Sept. 30, 2025 - 602798 2.3 million -
June 30, 2025 - 696163 2.1 million -
March 31, 2025 5 572567 3.3 million -

BTCY Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 4.0 million 736343
Sept. 30, 2025 3.9 million 704297
June 30, 2025 3.9 million 757193
March 31, 2025 3.7 million 724416

BTCY Revenue by Segment

Graph available only for paid members. Upgrade to see it.

BTCY

Price: $0.12

52 week price:
0.10
0.75

Payout Ratio Range:
-10.82%
-0.13%

Earnings Per Share: -0.16 USD

P/E Ratio: -1.87

Exchange: OQB

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 195900

Market Capitalization: 3.7 million

Links: